| Dr Katrina Krogh, MD | |
|
251 E Huron St Ste 7-132i, Chicago, IL 60611-2908 | |
| (312) 926-7913 | |
| (312) 926-3127 |
| Full Name | Dr Katrina Krogh |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 8 Years |
| Location | 251 E Huron St Ste 7-132i, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003270588 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | 036148320 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Genesis Healthcare Partners | 2163606807 | 185 |
News Archive
As health departments, community organizations and AIDS advocates around the country observe National HIV Testing Day today, AIDS Healthcare Foundation criticized the Centers for Disease Control's for its failure to implement its own landmark 2006 change it its official HIV testing guidelines that included the recommendation for routine testing of all individuals ages 13-64 for HIV as they visit or encounter routine healthcare settings.
Cardiac-gated CTA radiation doses can vary and be as high as 28.4 mSv (10 times the annual natural background radiation) in children, according to a recent study conducted by researchers from Duke University Medical Center in Durham, NC and Stanford University Medical Center in Palo Alto, CA.
Aloe Commodities International, Inc., Carrollton, Texas, is recalling 1600 bottles of Solutions IE Ageless Formula II, Lot numbers P2207 and P2221 because they contain a significantly higher-than-labeled level of vitamin D3. (Approximately 188,640 International Units (IU) are present in each serving size of 6 capsules instead of the intended level of 400 IU). The product is distributed by Solutions International, Inc., Orem, UT.
Tibotec Pharmaceuticals today announced its submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TMC278 (rilpivirine, as hydrochloride), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV. The proposed indication would make TMC278 available for once-daily use with other antiretroviral agents in treatment-naive HIV-1-infected adults.
A new study reveals that the liver's cannabinoid receptors could be targeted to fight liver cancer in some patients; and it offers a way to predict what treatments have the best chance of working.
› Verified 4 days ago
| Entity Name | Genesis Healthcare Partners Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548567498 PECOS PAC ID: 2163606807 Enrollment ID: O20110405000433 |
News Archive
As health departments, community organizations and AIDS advocates around the country observe National HIV Testing Day today, AIDS Healthcare Foundation criticized the Centers for Disease Control's for its failure to implement its own landmark 2006 change it its official HIV testing guidelines that included the recommendation for routine testing of all individuals ages 13-64 for HIV as they visit or encounter routine healthcare settings.
Cardiac-gated CTA radiation doses can vary and be as high as 28.4 mSv (10 times the annual natural background radiation) in children, according to a recent study conducted by researchers from Duke University Medical Center in Durham, NC and Stanford University Medical Center in Palo Alto, CA.
Aloe Commodities International, Inc., Carrollton, Texas, is recalling 1600 bottles of Solutions IE Ageless Formula II, Lot numbers P2207 and P2221 because they contain a significantly higher-than-labeled level of vitamin D3. (Approximately 188,640 International Units (IU) are present in each serving size of 6 capsules instead of the intended level of 400 IU). The product is distributed by Solutions International, Inc., Orem, UT.
Tibotec Pharmaceuticals today announced its submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TMC278 (rilpivirine, as hydrochloride), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV. The proposed indication would make TMC278 available for once-daily use with other antiretroviral agents in treatment-naive HIV-1-infected adults.
A new study reveals that the liver's cannabinoid receptors could be targeted to fight liver cancer in some patients; and it offers a way to predict what treatments have the best chance of working.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katrina Krogh, MD 303 E Chicago Ave, Ward 3-140 W127, Chicago, IL 60611-4296 Ph: (312) 503-8144 | Dr Katrina Krogh, MD 251 E Huron St Ste 7-132i, Chicago, IL 60611-2908 Ph: (312) 926-7913 |
News Archive
As health departments, community organizations and AIDS advocates around the country observe National HIV Testing Day today, AIDS Healthcare Foundation criticized the Centers for Disease Control's for its failure to implement its own landmark 2006 change it its official HIV testing guidelines that included the recommendation for routine testing of all individuals ages 13-64 for HIV as they visit or encounter routine healthcare settings.
Cardiac-gated CTA radiation doses can vary and be as high as 28.4 mSv (10 times the annual natural background radiation) in children, according to a recent study conducted by researchers from Duke University Medical Center in Durham, NC and Stanford University Medical Center in Palo Alto, CA.
Aloe Commodities International, Inc., Carrollton, Texas, is recalling 1600 bottles of Solutions IE Ageless Formula II, Lot numbers P2207 and P2221 because they contain a significantly higher-than-labeled level of vitamin D3. (Approximately 188,640 International Units (IU) are present in each serving size of 6 capsules instead of the intended level of 400 IU). The product is distributed by Solutions International, Inc., Orem, UT.
Tibotec Pharmaceuticals today announced its submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TMC278 (rilpivirine, as hydrochloride), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV. The proposed indication would make TMC278 available for once-daily use with other antiretroviral agents in treatment-naive HIV-1-infected adults.
A new study reveals that the liver's cannabinoid receptors could be targeted to fight liver cancer in some patients; and it offers a way to predict what treatments have the best chance of working.
› Verified 4 days ago
Mark Wang, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 251 E Huron St, Feinberg Pavilion, Chicago, IL 60611 Phone: 312-503-8144 Fax: 312-502-8249 | |
Sandeep Gurbuxani, Pathology Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Dr. Carmencita Garcia Senseng, MD Pathology Medicare: Medicare Enrolled Practice Location: 1900 W Polk St, Chicago, IL 60612 Phone: 312-864-7561 | |
Suman Setty, Pathology Medicare: Accepting Medicare Assignments Practice Location: 1740 W Taylor St, Chicago, IL 60612 Phone: 866-600-2273 | |
Jayme Brentan, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-695-9797 | |
Dr. Megan Elizabeth Sullivan, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-926-3211 |